Literature DB >> 12503819

Serial measurements of pharmacokinetics, DCE-MRI, blood flow, PET and biomarkers in serum/plasma--what is a useful tool in clinical studies of anti-angiogenic drugs?

K Mross1, S Fuxius, J Drevs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12503819     DOI： 10.5414/cpp40573

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN： 0946-1965            Impact factor:   1.366


× No keyword cloud information.
  4 in total

1.  Characteristics of dynamic magnetic resonance image enhancement in prolactinomas resistant to dopamine agonist therapy.

Authors:  Qinghua Guo; Bradley J Erickson; Alice Y Chang; Dana Erickson
Journal:  J Investig Med       Date:  2015-03       Impact factor: 2.895

Review 2.  Clinical biomarkers of angiogenesis inhibition.

Authors:  Aaron P Brown; Deborah E Citrin; Kevin A Camphausen
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

3.  Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).

Authors:  Alireza M Manuchehri; Thozhukat Sathyapalan; Martin Lowry; Lindsay W Turnbull; Christopher Rowland-Hill; Stephen L Atkin
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

4.  Mechanism of action of octreotide in acromegalic tumours in vivo using dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Thozhukat Sathyapalan; Martin Lowry; Lindsay W Turnbull; Chris Rowland-Hill; Stephen L Atkin
Journal:  Pituitary       Date:  2007       Impact factor: 4.107
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.